Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Jurković, , Jele,
DOB: 07-JAN-1953 (Age: 72)
Gender: female
Address:
Klesarski put 7b/8
34310 Pleternica (Croatia)
ID: 3583-291434-1 (ECI)
Report
Date: 22-FEB-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Opća županijska bolnica Požega
Osječka ulica 107
34000 Požega (Croatia)
Specimen
Collected: 22-FEB-2023

Chemistry

Test 22-FEB-2023 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.4 H 4 - 6 %
Glucose [Mass/volume] in Blood 93.6 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 12.7 7 - 50 mg/dL
Creatinine [Mass/volume] in Blood 0.6 0.5 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.2 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 141.5 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.0 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 107.6 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.8 L 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 158.4 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 101.2 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 105.4 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 32.8 L 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c, indicating prediabetes or suboptimal glycemic control. HDL cholesterol is low, which increases cardiovascular risk. Total CO₂ is slightly decreased, possibly reflecting mild metabolic acidosis or compensation. Other parameters, including renal function, electrolytes, and lipid profile, are within normal limits. Recommend further evaluation of glycemic control and cardiovascular risk management.